Zaire ebolavirus surveillance near the Bikoro region of the Democratic Republic of the Congo during the 2018 outbreak reveals presence of seropositive bats.
СтатьяПоддержка правительства СШАПоддержка исследования: вне правительства СШАResearch Support, N.I.H., IntramuralНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Seifert Stephanie N, Fischer Robert J, Kuisma Eeva, Badzi Nkoua Cynthia, Bounga Gerard, Akongo Marc-Joël, Schulz Jonathan E, Escudero-Pérez Beatriz, Akoundzie Beal-Junior, Ampiri Vishnou Reize Bani, Dieudonne Ankara, Indolo Ghislain Dzeret, Kaba Serge D, Louzolo Igor, Macosso Lucette Nathalie, Mavoungou Yanne, Miegakanda Valchy Bel-Bebi, Nina Rock Aimé, Samabide Kevin Tolovou, Ondzie Alain I, Ntoumi Francine, Muñoz-Fontela César, Mombouli Jean-Vivien, Olson Sarah H, Walzer Chris, Niama Fabien Roch, Munster Vincent J
Аннотация
On the 8th of May, 2018, an outbreak of Ebola virus disease (EVD) was declared, originating in the Bikoro region of the Democratic Republic of the Congo (DRC) near the border with neighboring Republic of the Congo (ROC). Frequent trade and migration occur between DRC and ROC-based communities residing along the Congo River. In June 2018, a field team was deployed to determine whether Zaire ebolavirus (Ebola virus (EBOV)) was contemporaneously circulating in local bats at the human-animal interface in ROC near the Bikoro EVD outbreak. Samples were collected from bats in the Cuvette and Likouala departments, ROC, bordering the Équateur Province in DRC where the Bikoro EVD outbreak was first detected. EBOV genomic material was not detected in bat-derived samples by targeted quantitative reverse transcription-polymerase chain reaction or by family-level consensus polymerase chain reaction; however, serological data suggests recent exposure to EBOV in bats in the region. We collected serum from 144 bats in the Cuvette department with 6.9% seropositivity against the EBOV glycoprotein and 14.3% seropositivity for serum collected from 27 fruit bats and one Molossinae in the Likouala department. We conclude that proactive investment in longitudinal sampling for filoviruses at the human-animal interface, coupled with ecological investigations are needed to identify EBOV wildlife reservoirs.